Soc. Generale Call 31 EVT 13.12.2.../ DE000SR4R5A6 /

1/15/2021 6:16:12 PM	Chg.-0.17	Bid9:59:41 PM	Ask-	Underlying	Strike price	Expiration date	Option type
5.99EUR	-2.76%	5.88 Bid Size: 765	- Ask Size: -	EVOTEC SE INH O.N.	31.00 EUR	12/13/2023	Call

GlobeNewswire 8/20/2020 CENTOGENE and Evotec Expand Collaboration Into Gaucher Disease

GlobeNewswire 2/7/2019 Evotec and Galapagos enter into collaboration in the field of fibrosis

GlobeNewswire 2/15/2018 EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE

GlobeNewswire 1/8/2018 APEIRON and Evotec Achieve First Milestone in Immuno-oncology Alliance with Sanofi

GlobeNewswire 9/14/2017 MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO

GlobeNewswire 11/29/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...

GlobeNewswire 11/10/2011 Evotec reports nine months results: Upside materialising

GlobeNewswire 11/3/2011 Evotec to Report Third Quarter Results on 10 November 2011

GlobeNewswire 10/27/2011 Evotec Achieves Two Milestones in Fragment-based Drug Discovery Alliance with Shionogi

GlobeNewswire 10/20/2011 Evotec and APEIRON Biologics start next project on the Cbl-b target

GlobeNewswire 10/5/2011 Evotec announces second multi-target collaboration with UCB

GlobeNewswire 9/29/2011 Evotec acquires remaining 30% of Indian Joint Venture from DIL

GlobeNewswire 9/9/2011 Directors' dealings:Evotec AG:Director's Dealings announcement according to §15a WpHG (the German Se...

GlobeNewswire 9/5/2011 Evotec and Roche agree to develop compound that could slow the progression of Alzheimer's disease

GlobeNewswire 9/5/2011 Evotec AG:Ad hoc:Evotec and Roche agree to develop compound that could slow the progression of Alzhe...

GlobeNewswire 8/18/2011 Evotec Receives Pre-clinical Milestone Payment as Part of its Discovery Alliance with Boehringer In...

GlobeNewswire 8/11/2011 Evotec reports 34% revenue and profitable earnings growth; revenue guidance raised

GlobeNewswire 8/11/2011 Evotec partners P2X7 antagonist programme, EVT 401, to a top tier global animal health company

GlobeNewswire 8/4/2011 Evotec to Report Second Quarter 2011 Results on 11 August 2011

GlobeNewswire 7/7/2011 Evotec announces multi-target collaboration with UCB in neurodegenerative and neurological diseases

GlobeNewswire 6/30/2011 Total voting rights:Evotec AG:Evotec AG: Publication pursuant to §26a WpHG (the German Securities Tr...

GlobeNewswire 6/27/2011 Evotec Achieves Milestone in an Ion Channel Drug Discovery Collaboration with Ono Pharmaceutical Co....

GlobeNewswire 6/24/2011 Evotec and Roche to jointly develop biomarkers in oncology

GlobeNewswire 6/6/2011 Evotec and Active Biotech Enter into Medicinal Chemistry Collaboration